Sagimet Biosciences Inc. (SGMT) NASDAQ

8.59

+2.73(+46.59%)

Updated at April 27 01:04PM

Currency In USD

Valuation

Market Cap191.49M
Enterprise Value156.54M
P/E Ratio-5.46
PEG Ratio0.35
Price/Sales Ratio0
Price/Book Ratio2.5
Enterprise/Revenue0
Enterprise/EBITDA-4.22

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.44
Return On Equity-0.41

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-56.89M
Net Income-51.04M
Diluted EPS-1.58

Balance Sheet

Total Cash113.12M
Total Cash/Share3.5
Total Debt78,000
Total Debt/Equity0
Current Ratio22.82
Book Value Per Share3.44

Price History

52-Week Change159.52
52-Week High11.41
52-Week Low3.03
Moving Average 50 Days5.43
Moving Average 200 Days6.82

Statistics

Average Volume516,303
Shares Outstanding32.02M
% Held by Institutions44.34

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A